Wolters Kluwer Health announced on November 13, 2026, that it had signed an agreement to acquire AgileMD for up to $100 million, a transaction that would add interactive clinical pathways and AI-powered patient-deterioration surveillance to its clinical business. The consideration consists of a $40 million upfront payment and a deferred balance contingent on performance targets. The transaction is expected to close in the first quarter of 2027 or sooner, subject to customary closing conditions…